A Retrospective Study of Multi‐agent Chemotherapy Including Either Cyclophosphamide or Lomustine as Initial Therapy for Canine High‐grade T‐cell Lymphoma (2011‐2017)

Australian Veterinary Journal- United States

doi 10.1111/avj.12847

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Clinical Response to a Lomustine/Cytarabine-Based Chemotherapy Protocol in a Case of Canine Large Granular Lymphocyte T-Cell Lymphoma With Spinal Involvement

Open Veterinary Journal
Veterinary
2018English

Primary T-Cell High-Grade Lymphoma of the Feline Uterus

Journal of Veterinary Medical Science
Veterinary
2016English

Multi-Center Phase Ii Study of Oral Azacitidine (Cc-486) Plus Chop as Initial Treatment for Peripheral T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Neoadjuvant Chemotherapy of Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy ( 'CEX' Therapy) for HER-2 Negative Breast Cancer, as Retrospective Study in Our Institute

Journal of Nippon Medical School
Medicine
2019English

Prospective Study of Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma Patients Who Are Not Suitable for Stem Cell Transplant or Multi-Agent Chemotherapy

British Journal of Haematology
Hematology
2018English

Tellomak: T-Cell Lymphoma Anti-Kir3dl2 Therapy: An Open Label, Multi-Cohort, Multi-Center, International Phase Ii Study Evaluating the Efficacy and Safety of Iph4102 Alone or in Combination With Chemotherapy in Patients With Advanced T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A National Retrospective Analysis of Clinical Outcomes Following Allogeneic Transplantation for High Grade B-Cell Lymphoma (Hgbl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Combination of 6-Thioguanine, Capecitabine, and Celecoxib With Temozolomide or Lomustine for Recurrent High-Grade Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2010English

A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone (LR-CD) for Untreated Low-Grade Non-Hodgkin Lymphoma Requiring Therapy

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy